Posted by Michael Wonder on 12 Oct 2022
FDA will begin accepting breakthrough devices for TAP pilot in 2023
11 October 2022 - The US FDA will start accepting products into its total product lifecycle advisory program (TAP) pilot starting in January.
The agency will only accept 15 cardiovascular breakthrough devices into the pilot program in the first year.
